The
NASDAQ
100 Pre-Market Indicator
is down -4.48 to 2,618.85. The total Pre-Market volume is currently
3,898,050 shares traded.
The following are the
most active stocks for the pre-market session
:
Sun Healthcare Group, Inc. (
SUNH
) is +2.21 at $8.35, with 8,990,321 shares traded. As reported in
the last short interest update the days to cover for SUNH is
10.639521; this calculation is based on the average trading volume
of the stock.
ONYX Pharmaceuticals, Inc. (
ONXX
) is +17.02 at $61.60, with 2,545,692 shares traded. ONXX's current
last sale is 123.2% of the target price of $50.
Celgene Corporation (
CELG
) is -6.9 at $60.26, with 1,199,294 shares traded. As reported by
Zacks, the current mean recommendation for CELG is in the "buy
range".
Bank of America Corporation (
BAC
) is -0.01 at $8.13, with 897,084 shares traded. BAC's current last
sale is 81.3% of the target price of $10.
Arena Pharmaceuticals, Inc. (
ARNA
) is +0.41 at $10.91, with 516,097 shares traded., following a
52-week high recorded in prior regular session.
Johnson & Johnson (
JNJ
) is -0.11 at $66.89, with 481,059 shares traded. Over the last
four weeks they have had 7 up revisions for the earnings forecast,
for the fiscal quarter ending Sep 2012. The consensus EPS forecast
is $1.26. As reported by Zacks, the current mean recommendation for
JNJ is in the "buy range".
Vodafone Group Plc (
VOD
) is -0.14 at $27.85, with 417,066 shares traded. As reported by
Zacks, the current mean recommendation for VOD is in the "buy
range".
Advanced Semiconductor Engineering, Inc. (
ASX
) is -0.0335 at $4.42, with 192,100 shares traded. ASX's current
last sale is 82.71% of the target price of $5.34.
BHP Billiton Limited (
BHP
) is -0.33 at $66.37, with 186,052 shares traded. As reported by
Zacks, the current mean recommendation for BHP is in the "buy
range".
ING Group, N.V. (
ING
) is +0.07 at $6.51, with 144,090 shares traded. ING's current last
sale is 52.71% of the target price of $12.35.
BP p.l.c. (
BP
) is -0.63 at $39.36, with 138,742 shares traded. As reported by
Zacks, the current mean recommendation for BP is in the "buy
range".
GenMark Diagnostics, Inc. (
GNMK
) is +0.11 at $4.40, with 110,750 shares traded. As reported by
Zacks, the current mean recommendation for GNMK is in the "strong
buy range".